Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center

References

1. ↵
   1. Şen H,
   2. Aydın B,
   3. Varan A,
   4. Akyüz C,
   5. Kutluk T,
   6. Yalçın B

   (2016) Neurofibromatosis type 1 and malignancy in childhood. Clin Genet 89, 341–345.
2. ↵
   1. DeBella K,
   2. Szudek J,
   3. Friedman JM

   (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105, 608–614.
3. ↵
   1. NIH Consens Statement Online

   Neurofibromatosis, 1–19.
4. ↵
   1. NIH

   (1997) The National Institutes of Health (NIH) Consensus Development Program. Acupunture.
5. ↵
   1. Boulanger JM,
   2. Larbrisseau A

   (2005) Neurofibromatosis type 1 in a pediatric population: Ste-Justine’s experience. Can J Neurol Sci 32, 225–231.
6. ↵
   1. Huson SM,
   2. Compston DA,
   3. Clark P,
   4. Harper PS

   (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26, 704–711.
7. ↵
   1. Friedman JM

   (2002) Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria. J Child Neurol 17, 548–554.
8. ↵
   1. Cnossen MH,
   2. De Goede-Bolder A,
   3. Van Den Broek KM,
   4. Waasdorp CME,
   5. Oranje AP,
   6. Stroink H,
   7. et al.

   (1998) A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child 78, 408–412.
9. ↵
   1. Yapijakis C,
   2. Pachis N,
   3. Natsis S,
   4. Voumvourakis C

   (2016) Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors? In Vivo (Brooklyn) 30, 315–320.
10. ↵
    1. Rodríguez AD,
    2. Moreno GM,
    3. Santo-Domingo YM,
    4. Martín AH,
    5. Roca JES,
    6. Rojas MRF,
    7. et al.

    (2015) [Phenotypic and genetic features in neurofibromatosis type 1 in children]. An Pediatr (Barc) 83, 173–182, . Spanish.
11. ↵
    1. Karajannis MA,
    2. Ferner RE

    (2015) Neurofibromatosis-related tumors: Emerging biology and therapies. Curr Opin Pediatr 27, 26–33.
12. ↵
    1. Boyd KP,
    2. Korf BR,
    3. Theos A

    (2009) Neurofibromatosis type 1. J Am Acad Dermatol 61, 1–14.
13. ↵
    1. Evans DGR,
    2. Huson SM,
    3. Birch JM

    (2012) Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res 2, 17.
14. ↵
    1. Uusitalo E,
    2. Rantanen M,
    3. Roope AK,
    4. Pöyhönen M,
    5. Leppävirta J,
    6. Ylä-Outinen H,
    7. Riccardi VM,
    8. Pukkala Eero,
    9. Pitkäniemi Janne,
    10. Peltonen Sirkku,
    11. Peltonen Juha

    (2016) Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1. J Clin Oncol 34, 1978–1986.
15. ↵
    1. Evans DGR,
    2. Salvador H,
    3. Chang VY,
    4. Erez A,
    5. Voss SD,
    6. Schneider KW,
    7. et al.

    (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23, e46–e53.
16. ↵
    1. Cimino PJ,
    2. Gutmann DH

    (2018) Neurofibromatosis type 1. Handb Clin Neurol 148, 799–811.
17. ↵
    1. Ferner RE

    (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol [Internet] 6, 340–351.
18. ↵
    1. Melloni G,
    2. Eoli M,
    3. Cesaretti C,
    4. Bianchessi D,
    5. Ibba MC,
    6. Esposito S,
    7. et al.

    (2019) Risk of optic pathway glioma in neurofibromatosis type 1: No evidence of genotype–phenotype correlations in a large independent cohort. Cancers (Basel) 11.
19. ↵
    1. Campen Cynthia J,
    2. Gutmann David H

    (2018) Optic Pathway Gliomas in Neurofibromatosis Type 1. J Child Neurol 33, 73–81.
20. ↵
    1. Mahdi J,
    2. Shah AC,
    3. Sato A,
    4. Morris SM,
    5. Mckinstry RC,
    6. Listernick R,
    7. et al.

    (2017) A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Am Acad Neurol 88, 1584–1589.
21. ↵
    1. Peltonen J,
    2. Pitkäniemi J,
    3. Pöyhönen M,
    4. Uusitalo E,
    5. Kallionpää RA,
    6. Peltonen S,
    7. et al.

    (2019) Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study. Int J Cancer 145, 2926–2932.
22. ↵
    1. Pascual-Castroviejo I,
    2. Pascual-Pascual SI,
    3. Viaño J,
    4. Carceller F,
    5. Gutierrez-Molina M,
    6. Morales C,
    7. et al.

    (2010) Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst 26, 1599–1603.
23. ↵
    1. Zöller ME,
    2. Rembeck B,
    3. Odén A,
    4. Samuelsson M,
    5. Angervall L

    (2000) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79, 2125–2131.